Article Details

Improved outcome for prostate cancer patients in Phase III PROpel trial

Retrieved on: 2022-06-22 14:46:48

Tags for this article:

Click the tags to see associated articles and topics

Improved outcome for prostate cancer patients in Phase III PROpel trial. View article details on hiswai:

Excerpt

Following interim reports from AstraZeneca last September that indicated a trend towards improved radiographic progression-free survival (rPFS) and ...

Article found on: www.europeanpharmaceuticalreview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up